tiprankstipranks
Trending News
More News >
Bavarian Nordic A/S (BVNRY)
OTHER OTC:BVNRY
US Market
Advertisement

Bavarian Nordic (BVNRY) Earnings Dates, Call Summary & Reports

Compare
172 Followers

Earnings Data

Report Date
Nov 14, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
Last Year’s EPS
0.04
Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 22, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call demonstrated strong revenue growth and successful vaccine sales, particularly in the Travel Health and Public Preparedness segments. However, there were some challenges, such as declines in certain vaccine sales and concerns regarding Chikungunya outbreaks. Overall, the positive aspects significantly outweigh the challenges.
Company Guidance
In the recent Bavarian Nordic conference call, the company provided updated guidance reflecting a robust financial performance for the first half of 2025. The company reported a 33% increase in revenue year-over-year, achieving an EBITDA margin of 32%, driven by the sale of 5 million vaccine doses. The Travel Health segment saw a 24% growth, with rabies and TBE vaccines contributing significantly, whereas Public Preparedness secured contracts worth DKK 3.1 billion, exceeding the base business expectations of DKK 1.5 billion to DKK 2 billion. The company has maintained its EBITDA margin guidance for the year at 26% to 30% and expects a 42% margin, including a DKK 810 million net income from the sale of a Priority Review Voucher. Additionally, Bavarian Nordic announced a refined revenue guidance, raising the lower end to DKK 6 billion, reflecting confidence in achieving strong year-end results.
Strong Revenue Growth
Bavarian Nordic reported a 33% improvement in revenues for the first half of 2025 compared to the previous year, resulting in an EBITDA margin of 32%.
Successful Vaccine Sales
The company sold 5 million doses of vaccines, saving 5 million lives in the first half of the year.
Travel Health Segment Growth
Travel Health saw a 24% improvement, driven by strong sales of rabies and TBE vaccines. The rabies vaccine saw a 26% growth in Q2 and 37% for the first half of the year.
Chikungunya Vaccine Launch
The Chikungunya vaccine is now approved in the EU, U.S., and U.K., with launches in Germany and France. The company expects this vaccine to be a key asset in the Travel Health portfolio.
Public Preparedness Contracts
Bavarian Nordic secured DKK 3.1 billion in Public Preparedness contracts, exceeding the base business expectations.
Priority Review Voucher Sale
The sale of a Priority Review Voucher resulted in net income of DKK 810 million, potentially improving the EBITDA margin to 42% by year-end.

Bavarian Nordic (BVNRY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BVNRY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 14, 2025
2025 (Q3)
- / -
0.044
Aug 22, 2025
2025 (Q2)
- / 0.24
0.16146.58% (+0.07)
May 09, 2025
2025 (Q1)
- / 0.13
-0.071285.92% (+0.20)
Mar 05, 2025
2024 (Q4)
- / 0.47
0.565-17.17% (-0.10)
Nov 15, 2024
2024 (Q3)
- / 0.04
-0.213120.66% (+0.26)
Aug 22, 2024
2024 (Q2)
- / 0.16
0.336-52.08% (-0.18)
May 08, 2024
2024 (Q1)
- / -0.07
0.232-130.60% (-0.30)
Feb 21, 2024
2023 (Q4)
- / 0.56
0.097482.47% (+0.47)
Nov 16, 2023
2023 (Q3)
- / -0.21
0.008-2762.50% (-0.22)
Aug 23, 2023
2023 (Q2)
- / 0.34
-0.161308.70% (+0.50)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BVNRY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 22, 2025
$12.38$12.50+0.97%
May 09, 2025
$7.82$8.29+6.01%
Mar 05, 2025
$7.69$8.08+5.07%
Nov 15, 2024
$9.68$7.96-17.77%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Bavarian Nordic A/S (BVNRY) report earnings?
Bavarian Nordic A/S (BVNRY) is schdueled to report earning on Nov 14, 2025, Before Open (Confirmed).
    What is Bavarian Nordic A/S (BVNRY) earnings time?
    Bavarian Nordic A/S (BVNRY) earnings time is at Nov 14, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BVNRY EPS forecast?
          Currently, no data Available
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis